CNS Pharmaceuticals Inc. (CNSP)
undefined
undefined%
At close: undefined
0.10
2.31%
Pre-market Dec 16, 2024, 05:36 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -18.85M -15.27M -14.04M -9.46M -3.88M -7.39M -219.36K
Depreciation & Amortization 4.13K 11.76K 13.07K 11.10K 1.96K - -
Stock-Based Compensation 1.01M 1.20M 1.72M 1.29M 477.10K 110.24K 119.85K
Other Working Capital 2.38M 1.46M -1.82M 176.95K -579.23K 12.41K -10.25K
Other Non-Cash Items 498.00 337.25K 714.87K 1.58K 270.31K 6.48M 2.42K
Deferred Income Tax - - -714.87K - - - -
Change in Working Capital 3.70M 3.16M -1.24M 833.78K -425.62K 83.78K 47.25K
Operating Cash Flow -14.14M -10.56M -13.54M -7.32M -3.55M -716.38K -112.20K
Capital Expenditures -3.90K -4.42K -5.75K -17.95K -20.12K - -
Acquisitions - - - - - - -
Purchase of Investments - - - - - - -
Sales Maturities Of Investments - - - - - - -
Other Investing Acitivies - - - - - - -
Investing Cash Flow -3.90K -4.42K -5.75K -17.95K -20.12K - -
Debt Repayment - - - -43.08K -35.00K 300.00K -
Common Stock Repurchased - - - - - - -
Dividend Paid - - - - - - -
Other Financial Acitivies 2.32M 15.61M 4.51M -45.00K - 860.98K 222.74K
Financial Cash Flow 4.64M 15.61M 4.51M 14.13M 10.26M 1.16M 222.74K
Net Cash Flow -9.51M 5.05M -9.03M 6.80M 6.69M 444.59K 110.54K
Free Cash Flow -14.14M -10.56M -13.54M -7.34M -3.57M -716.38K -112.20K